ASEP Medical Holdings (XCNQ:ASEP) OCF Margin %: -98.63% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XCNQ:ASEP ASEP Medical Holdings Inc XCNQ:ASEP
19 GF Score
Price C$0.13
! 4 Warning Signs
View Full Analysis

What is ASEP Medical Holdings OCF Margin %?

ASEP Medical Holdings XCNQ:ASEP 19 OCF Margin % is -98.63% as of Mar. 2026. GuruFocus rates XCNQ:ASEP with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 950 Biotechnology companies, ASEP Medical Holdings ranks worse than 65.89% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. ASEP Medical Holdings's Cash Flow from Operations for the three months ended in Mar. 2026 was C$-0.07 Mil. ASEP Medical Holdings's Revenue for the three months ended in Mar. 2026 was C$0.07 Mil. Therefore, ASEP Medical Holdings's OCF Margin % for the quarter that ended in Mar. 2026 was -98.63%.

As of today, ASEP Medical Holdings's current OCF Yield % is -49.27%.

The historical rank and industry rank for ASEP Medical Holdings's OCF Margin % or its related term are showing as below:

XCNQ:ASEP' s OCF Margin % Range Over the Past 10 Years
Min: -12919.05   Med: -302.08   Max: -113.09
Current: -301.78

During the past 5 years, the highest OCF Margin % of ASEP Medical Holdings was -113.09%. The lowest was -12919.05%. And the median was -302.08%.

XCNQ:ASEP's OCF Margin % is ranked worse than
65.89% of 950 companies
in the Biotechnology industry
Industry Median: -65.71 vs XCNQ:ASEP: -301.78

ASEP Medical Holdings OCF Margin % Related Terms

ASEP Medical Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for ASEP Medical Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASEP Medical Holdings OCF Margin % Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
0.00 0.00 -12,919.05 -113.09 -302.08

ASEP Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.00 -277.03 -777.33 -136.52 -98.63

XCNQ:ASEP vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, ASEP Medical Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASEP Medical Holdings OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's OCF Margin % distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's OCF Margin % falls into.


XCNQ:ASEP
19GF Score
ASEP Medical Holdings Inc XCNQ:ASEP
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASEP Medical Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

ASEP Medical Holdings's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.018/0.337
=-302.08 %

ASEP Medical Holdings's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.072/0.073
=-98.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -98.63% mean?
ASEP Medical Holdings (XCNQ:ASEP) has a OCF Margin % of -98.63% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ASEP Medical Holdings and its competitors. According to the industry distribution chart, ASEP Medical Holdings ranks #626 out of 950 companies in the Biotechnology industry, placing it in the top 65.9%.
Is ASEP Medical Holdings' OCF Margin % too high?
ASEP Medical Holdings' current OCF Margin % is -98.63%. Based on the distribution chart, ASEP Medical Holdings ranks #626 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, ASEP Medical Holdings has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #626 out of 950 companies for OCF Margin %. This places ASEP Medical Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ASEP Medical Holdings and its competitors. ASEP Medical Holdings's current OCF Margin % is -98.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (XCNQ:ASEP) has a current OCF Margin % of -98.63%. The current OCF Margin % is -98.63%. ASEP Medical Holdings' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ASEP Medical Holdings (XCNQ:ASEP), the current OCF Margin % is -98.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ASEP Medical Holdings Business Description

Other Exchanges JJ80:Germany
Address 4400 Chatterton Way, Unit 202, Victoria, BC, CAN, V8X 5J2
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
19GF Score

Get the complete analysis for XCNQ:ASEP

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.13
Price